Chronic pain – the role of pharmacists
Pharmacists play a vital role supporting patients with chronic pain.
Around 1 in 5 Australians experience chronic pain; this rises to 1 in 3...
Expect an increase in demand for long-acting injectable buprenorphine
Changes to the Opioid Dependence Treatment program could make long-acting injectable buprenorphine the best option for many people.
Changes to PBS antibiotic prescribing
In a move aimed at reducing antibiotic resistance, the Pharmaceutical Benefits Advisory Committee (PBAC) has recommended that four of the most widely prescribed antibiotics...
TGA approves Pfizer booster for teens
Pfizer’s Comirnaty COVID-19 vaccine has been provisionally approved by the Therapeutic Goods Administration (TGA) for use as a booster in those aged 16–17 years.
Can I eat where I compound?
Compounding environments must be designed to minimise contamination risk — including keeping meal breaks well away from the bench.
Oral PDE4 inhibitors in the management of stable COPD
Almost 1.45 million Australians have some form of chronic obstructive pulmonary disease (COPD). This equates to one in seven Australians over 40 suffering from...
